GLOW
Research Use Only · Not for Human Consumption
A three-peptide research blend of BPC-157, TB-500, and GHK-Cu supplied in lyophilized form.
Multi-peptide blend for dermal research applications
Blend Components
| Component | CAS# | Formula | Molar Mass |
|---|---|---|---|
| CAS Number: BPC-157 | Molecular Formula: 137525-51-0 | Molar Mass: C62H98N16O22 | 1419.55 g/mol |
| TB-500 | 77591-33-4 | C212H350N56O78S | 4963.44 g/mol |
| GHK-Cu | 49557-75-7 | C14H22CuN6O4 | 401.91 g/mol |
What is GLOW?
GLOW is a multi-peptide research blend for studying tissue remodeling, cellular migration, and collagen synthesis pathways in vitro. It combines BPC-157, TB-500, and GHK-Cu to enable investigation of complementary extracellular matrix signaling mechanisms.
GLOW is a blend that brings together three peptides that were each first described through separate research paths. BPC-157 emerged from Croatian gastric-juice studies in the 1990s. TB-500 (Thymosin Beta-4) traces to Allan Goldstein's thymosin work in the 1960s. GHK-Cu was first described by Dr. Loren Pickart in 1973 while studying human blood plasma.
Each peptide had built its own preclinical research base before being combined in this blend. BPC-157 has been examined in vitro and in animal models for interactions with angiogenic signaling. TB-500 has been studied for its influence on cellular migration in laboratory models. GHK-Cu has been examined in vitro for associations with gene-expression and tissue-remodeling pathways.
GLOW combines these three peptides to let researchers examine complementary in-vitro mechanisms — angiogenic signaling, cellular migration, and extracellular-matrix gene expression — within a single lyophilized preparation. This product is intended for research use only.
How should GLOW be stored?
Peptide Foundry research peptides are supplied lyophilized (freeze-dried). Keep sealed vials cool, dry, and protected from light until reconstitution.
After reconstitution, refrigerate prepared solutions and use sterile technique. For general laboratory diluent and handling notes, see lyophilized peptide reconstitution.
Certificate of Analysis
Every batch of GLOW is tested by ILS Laboratories, an ISO/IEC 17025–accredited lab, for purity, identity, heavy metals, sterility, endotoxin, and a fentanyl screen. The full certificate is below.
GLOW · 50mg/10mg/10mg
Peptide Purity · HPLC @ 214 nm
99.65% — exceptional research-grade purity
Area-normalized against all peptide-related peaks. Identity confirmed by chromatographic retention-time match to a reference standard.
Every test on this certificate
COA documents are updated with each new batch. Contact support for batch-specific documentation.
Compare research materials
GHK-Cu, GLOW and KLOW: what’s in each vial?
Compare the standalone material with the blends by named components and labeled amounts. The amounts below describe vial contents, not preparation instructions.
Related material
GHK-CU
- GHK-CU
- 100 mg
This product
GLOW
- GHK-Cu
- 50 mg
- BPC-157
- 10 mg
- TB-500
- 10 mg
Related material
KLOW
- GHK-Cu
- 50 mg
- BPC-157
- 10 mg
- TB-500
- 10 mg
- KPV
- 10 mg
For blend composition and documentation checks, read GLOW vs KLOW and how to read a multi-peptide blend COA. All materials are for laboratory research only.
Related Research Compounds
Frequently purchased with GLOW
Add all 3 items to your cart
$260
Further reading
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988.
- Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta-4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-2151.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011;17(16):1612-1632.
